Catalyst Wire Dossier Catalyst Wire Dossier

Cafusertib hydrochloride

cafusertib hydrochloride · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cafusertib hydrochloride, covering 2014-05-16 to 2014-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours [Phase 1]

See pricing